Literature DB >> 6750034

Coordinate production of three exoenzymes of Staphylococcus staphylolyticus.

S A Larrimore, S B Clark, J M Robinson, H E Heath, G L Sloan.   

Abstract

Staphylococcus staphylolyticus produced three exoenzymes (a staphylolytic endopeptidase, a hexosaminidase and a protease) coordinately under a range of conditions of induction and repression by various peptides and carbohydrates. Mutants of S. staphylolyticus were isolated and shown to have pleiotropic variations in the production of the three enzymes. Hypo- or hyperproducing mutants of one enzyme were invariably hypo- or hyperproducers for the other two enzymes. Mutants that had lost the ability to produce one of the exoenzymes invariably failed to produce the other two enzymes. Revertants isolated from non-producers that regained the ability to produce one of the exoenzymes always regained the ability to produce the other two as well. These results suggest that the three exoenzymes share a common regulatory or processing mechanism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6750034     DOI: 10.1099/00221287-128-7-1529

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  4 in total

1.  Modified simplified method for isolation of lysostaphin from the culture filtrate of Staphylococcus staphylolyticus.

Authors:  I Márová; V Dadák
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

2.  Simple screening method for identification of nonpleiotropic mutants for exoenzyme production.

Authors:  K E Rose; H E Heath; G L Sloan
Journal:  Appl Environ Microbiol       Date:  1985-05       Impact factor: 4.792

3.  Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans.

Authors:  P A Recsei; A D Gruss; R P Novick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 4.  Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.

Authors:  Maria do Carmo de Freire Bastos; Bruna Gonçalves Coutinho; Marcus Lívio Varella Coelho
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.